Find a Trial

Trial Summary


Protocol No.PHO-COG-AREN1721
StatusOPEN TO ACCRUAL
Principal InvestigatorBatra, Sandeep
ScopeNational
PhasePhase II
Age GroupAdults and Children
TitleA Randomized Phase 2 Trial of Axitinib/Nivolumab Combination Therapy vs. Single Agent Axitinib or Nivolumab for the Treatment of TFE/Translocation Renal Cell Carcinoma (tRCC) Across All Age Groups
Applicable Disease SitesKidney
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactHeather Claussen, Phone:
    Pager:
    Email: heclauss@iu.edu